back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-05 12:51 Tx date 2024-03-04 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-152,955
-309 vol $495.00 each |
52,545 | |
| Filed 2024-03-05 12:42 Tx date 2024-01-21 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-50,910.75
-121 vol $420.75 each |
52,485 | |
| Filed 2024-03-05 12:37 Tx date 2024-01-14 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-17,325
-42 vol $412.50 each |
8,542 | |
| Filed 2024-02-21 11:33 Tx date 2024-02-20 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,921
+41,600 vol $0.3587 each |
43,959 | |
| Filed 2023-12-26 12:55 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Tegge, Jonathan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,100
+30,000 vol $0.37 each |
31,400 | |
| Filed 2023-12-26 11:27 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,627
+7,100 vol $0.37 each |
8,584 | |
| Filed 2023-12-26 11:23 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Lemerond, Nicole
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,627
+7,100 vol $0.37 each |
8,500 | |
| Filed 2023-12-26 11:20 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Grove, Janet
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,627
+7,100 vol $0.37 each |
8,500 | |
| Filed 2023-12-26 11:18 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$14,800
+40,000 vol $0.37 each |
48,000 | |
| Filed 2023-12-26 11:13 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Baldasare, Bryan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,627
+7,100 vol $0.37 each |
8,500 | |
| Filed 2023-12-26 11:04 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,650
+45,000 vol $0.37 each |
52,606 | |
| Filed 2023-12-26 11:00 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,650
+45,000 vol $0.37 each |
52,854 | |
| Filed 2023-12-26 10:55 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,050
+65,000 vol $0.37 each |
75,494 | |
| Filed 2023-12-26 10:50 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,320
+136,000 vol $0.37 each |
162,139 | |
| Filed 2023-12-06 08:18 Tx date 2023-12-05 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-311,322
-848 vol $367.13 each |
10,494 | |
| Filed 2023-08-31 13:08 Tx date 2023-08-31 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-221,215.50
-327 vol $676.50 each |
7,854 | |
| Filed 2023-05-16 12:14 Tx date 2023-05-16 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-127,908
-152 vol $841.50 each |
8,181 | |
| Filed 2023-05-16 12:10 Tx date 2023-05-16 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-408,127.50
-485 vol $841.50 each |
7,606 | |
| Filed 2023-05-16 12:08 Tx date 2023-05-16 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,529,847
-1,818 vol $841.50 each |
26,139 | |
| Filed 2023-03-08 13:07 Tx date 2023-03-08 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-696,918.75
-545 vol $1,278 each |
8,333 | |
| Filed 2023-03-08 13:05 Tx date 2023-03-08 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-696,918.75
-545 vol $1,278 each |
27,957 | |
| Filed 2023-03-08 13:02 Tx date 2023-03-08 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-78,003.75
-61 vol $1,278 each |
8,091 | |
| Filed 2022-12-19 16:36 Tx date 2022-12-12 |
$INM
InMed Pharmaceuticals Inc. |
Tegge, Jonathan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,400 | ||
| Filed 2022-12-19 15:27 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,495
+840 vol $1.78 each |
1,484 | |
| Filed 2022-12-19 15:25 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$26,700
+15,000 vol $1.78 each |
28,502 | |
| Filed 2022-12-19 15:05 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,476
+4,200 vol $1.78 each |
8,152 | |
| Filed 2022-12-19 13:47 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,476
+4,200 vol $1.78 each |
8,878 | |
| Filed 2022-12-19 13:45 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,350
+7,500 vol $1.78 each |
11,342 | |
| Filed 2022-12-19 13:07 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,476
+4,200 vol $1.78 each |
8,000 | |
| Filed 2022-12-19 13:05 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Lemerond, Nicole
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,495
+840 vol $1.78 each |
1,400 | |
| Filed 2022-12-19 13:03 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Baldasare, Bryan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,495
+840 vol $1.78 each |
1,400 | |
| Filed 2022-12-19 12:57 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Grove, Janet
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,495
+840 vol $1.78 each |
1,400 | |
| Filed 2022-12-19 11:33 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Li, Sarah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,408
+3,600 vol $1.78 each |
4,002 | |
| Filed 2022-11-18 17:00 Tx date 2022-11-16 |
$INM
InMed Pharmaceuticals Inc. |
Li, Sarah
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
402 | ||
| Filed 2022-11-17 15:18 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-17 15:17 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,850
+7,500 vol $2.78 each |
||
| Filed 2022-11-17 15:15 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-17 15:14 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-17 15:08 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,700
+15,000 vol $2.78 each |
||
| Filed 2022-11-15 18:08 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-15 18:06 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-15 18:04 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-15 18:02 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,850
+7,500 vol $2.78 each |
||
| Filed 2022-11-15 17:59 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,700
+15,000 vol $2.78 each |
||
| Filed 2022-11-15 18:08 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
8,000 | |
| Filed 2022-11-15 18:06 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
8,152 | |
| Filed 2022-11-15 18:04 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
8,878 | |
| Filed 2022-11-15 18:02 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,850
+7,500 vol $2.78 each |
11,342 | |
| Filed 2022-11-15 17:59 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$41,700
+15,000 vol $2.78 each |
28,502 | |
| Filed 2022-10-26 13:20 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-292,412 vol |
12,183 | |
| Filed 2022-10-12 18:13 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-292,411 vol |
||
| Filed 2022-10-25 18:23 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,644 vol |
2,359 | |
| Filed 2022-10-25 17:16 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-5,819 vol |
240 | |
| Filed 2022-10-12 18:17 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-5,817 vol |
||
| Filed 2022-10-12 17:51 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,643 vol |
||
| Filed 2022-10-13 13:51 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-15,478 vol |
644 | |
| Filed 2022-10-12 18:28 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Lemerond, Nicole
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-13,440 vol |
560 | |
| Filed 2022-10-12 18:26 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Grove, Janet
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-13,440 vol |
560 | |
| Filed 2022-10-12 18:24 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Baldasare, Bryan
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-13,440 vol |
560 | |
| Filed 2022-10-12 18:20 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-18,181 vol |
758 | |
| Filed 2022-10-12 18:19 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-15,478 vol |
644 | |
| Filed 2022-10-12 18:17 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-5,817 vol |
242 | |
| Filed 2022-10-12 18:16 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-94,835 vol |
3,952 | |
| Filed 2022-10-12 18:13 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-292,411 vol |
12,184 | |
| Filed 2022-10-12 18:13 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-91,200 vol |
3,800 | |
| Filed 2022-10-12 18:10 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,221 vol |
51 | |
| Filed 2022-10-12 18:10 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-112,291 vol |
4,678 | |
| Filed 2022-10-12 18:00 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-509 vol |
21 | |
| Filed 2022-10-12 17:58 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-92,218 vol |
3,842 | |
| Filed 2022-10-12 17:51 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-56,643 vol |
2,360 | |
| Filed 2022-10-12 17:48 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-324,074 vol |
13,502 | |
| Filed 2022-08-10 12:27 Tx date 2022-08-08 |
$INM
InMed Pharmaceuticals Inc. |
Lemerond, Nicole
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
14,000 | ||
| Filed 2022-06-02 11:47 Tx date 2022-06-02 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-202,494.60
-13,636 vol $14.85 each |
337,576 | |
| Filed 2022-06-02 11:38 Tx date 2022-06-02 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-22,497.75
-1,515 vol $14.85 each |
98,787 | |
| Filed 2022-05-20 14:36 Tx date 2022-05-12 |
$INM
InMed Pharmaceuticals Inc. |
Baldasare, Bryan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
14,000 | ||
| Filed 2022-05-20 13:38 Tx date 2022-05-12 |
$INM
InMed Pharmaceuticals Inc. |
Baldasare, Bryan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-14 18:49 Tx date 2022-04-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,659
+14,160 vol $0.89 each |
59,003 | |
| Filed 2022-04-14 18:19 Tx date 2022-04-14 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,925
+22,720 vol $0.88 each |
||
| Filed 2022-04-14 10:06 Tx date 2022-04-13 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,276
+8,560 vol $0.85 each |
44,843 | |
| Filed 2022-02-24 12:03 Tx date 2022-02-23 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,050
+5,000 vol $1.01 each |
96,060 | |
| Filed 2022-02-24 11:35 Tx date 2022-02-11 |
$INM
InMed Pharmaceuticals Inc. |
Grove, Janet
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
14,000 | ||
| Filed 2022-02-23 15:42 Tx date 2022-02-23 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-36,996.30
-3,030 vol $12.21 each |
100,302 | |
| Filed 2022-01-24 16:15 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-78,059.24
-12,121 vol $6.44 each |
103,332 | |
| Filed 2022-01-24 13:30 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,438
+5,000 vol $1.09 each |
11,515 | |
| Filed 2022-01-24 12:44 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,303 vol |
16,122 | |
| Filed 2022-01-24 12:42 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-24,242 vol |
16,122 | |
| Filed 2022-01-24 12:20 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-30,303 vol |
16,122 | |
| Filed 2022-01-24 11:45 Tx date 2022-01-24 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-121,212 vol |
351,212 | |
| Filed 2022-01-06 18:19 Tx date 2022-01-06 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,710
+8,500 vol $1.26 each |
304,595 | |
| Filed 2022-01-01 19:06 Tx date 2021-12-29 |
$INM
InMed Pharmaceuticals Inc. |
Cutler, Adam
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,240
+7,000 vol $1.32 each |
46,425 | |
| Filed 2021-12-30 21:31 Tx date 2021-12-29 |
$INM
InMed Pharmaceuticals Inc. |
Sazdanoff, Catherine
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,240
+7,000 vol $1.32 each |
29,091 | |
| Filed 2021-12-30 21:27 Tx date 2021-12-29 |
$INM
InMed Pharmaceuticals Inc. |
Garner, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,240
+7,000 vol $1.32 each |
40,364 | |
| Filed 2021-12-30 21:24 Tx date 2021-12-29 |
$INM
InMed Pharmaceuticals Inc. |
Hull, Andrew Harold
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$9,240
+7,000 vol $1.32 each |
46,425 | |
| Filed 2021-12-30 21:15 Tx date 2021-12-30 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,736
+8,093 vol $1.33 each |
296,095 | |
| Filed 2021-11-15 13:31 Tx date 2021-11-15 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,845
+5,000 vol $1.37 each |
288,002 | |
| Filed 2021-11-02 18:22 Tx date 2021-11-02 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
283,002 | ||
| Filed 2021-11-02 18:17 Tx date 2021-11-02 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
95,000 | ||
| Filed 2021-10-20 15:49 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,000
+60,000 vol $1.40 each |
150,303 | |
| Filed 2021-10-20 13:56 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Mancini, Alexandra Diane Janet
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,000
+35,000 vol $1.40 each |
115,453 | |
| Filed 2021-10-20 12:14 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Woudenberg, Michael Henry
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+30,000 vol |
91,060 | |
| Filed 2021-10-19 18:52 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Hsu, Eric Chih-Hsien
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+35,000 vol |
116,969 | |
| Filed 2021-10-19 12:26 Tx date 2021-10-18 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
472,424 | |
| Filed 2021-09-30 11:41 Tx date 2021-09-29 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,224
+8,800 vol $1.73 each |
36,283 | |
| Filed 2021-09-29 22:07 Tx date 2021-09-28 |
$INM
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,840
+5,000 vol $1.77 each |
6,515 | |
| Filed 2021-09-29 22:06 Tx date 2021-09-28 |
$INM
InMed Pharmaceuticals Inc. |
Colwill, Bruce
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,840
+5,000 vol $1.77 each |
||
| Filed 2021-09-29 11:24 Tx date 2021-09-28 |
$INM
InMed Pharmaceuticals Inc. |
Adams, Eric Ashley
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,984
+11,400 vol $1.75 each |
27,483 | |
| Filed 2016-05-12 Tx date 2016-04-21 |
$INM
Northair Silver Corp. |
Zaradic, Andrea Melissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-1,400,000 vol |
0 | |
| Filed 2016-05-12 Tx date 2016-04-21 |
$INM
Northair Silver Corp. |
Zaradic, Andrea Melissa
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-500,000 vol |
0 | |
| Filed 2015-07-21 Tx date 2015-07-21 |
$INM
Northair Silver Corp. |
Scott, Robert James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,250
+50,000 vol $0.045 each |
425,000 | |
| Filed 2015-06-10 Tx date 2015-06-10 |
$INM
Northair Silver Corp. |
Scott, Robert James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,125
+225,000 vol $0.045 each |
375,000 | |
| Filed 2015-05-20 Tx date 2015-05-15 |
$INM
Northair Silver Corp. |
Scott, Robert James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,250
+150,000 vol $0.055 each |
150,000 | |
| Filed 2015-05-20 Tx date 2014-12-08 |
$INM
Northair Silver Corp. |
Scott, Robert James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|